Valuation : Ipsen

Market Cap 13.75B 15.94B 12.93B 11.78B 22.16B 1,513B 22.28B 153B 59.51B 770B 59.85B 58.55B 2,552B P/E 2026 *
14x
P/E 2027 * 14.3x
Enterprise Value 12.51B 14.5B 11.77B 10.72B 20.16B 1,377B 20.27B 139B 54.15B 700B 54.46B 53.28B 2,322B EV / Sales 2026 *
2.75x
EV / Sales 2027 * 2.47x
Free-Float
40.65%
Yield 2026 *
0.92%
Yield 2027 * 0.91%
1 week+1.08%
Current month+2.82%
1 month+9.54%
3 months+10.11%
6 months+2.01%
Current year+40.92%
1 week 160.8
Extreme 160.8
169.3
1 month 153.1
Extreme 153.1
169.3
Current year 116
Extreme 116
174
1 year 109.9
Extreme 109.9
174
3 years 87.95
Extreme 87.95
174
5 years 77
Extreme 77
174
10 years 34.2
Extreme 34.2
174
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2020
Chief Executive Officer 57 31/12/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 29/08/2005
Chairman 68 21/11/2010
Director/Board Member 69 31/05/2012
Date Insider Type Main position Quantity % Market Cap. Importance
24/08/26 Sell

Chairman

-3,840 0.0046%
18/08/26 Sell

Chief Executive Officer

-1,000 0.0012%
17/08/26 Sell

Chief Executive Officer

-2,000 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.08%+44.94%+44.69% 15.94B
+0.55%-1.60%+59.20%+109.68% 1,034B
+1.10%+1.62%+54.10%+70.76% 654B
-0.65%-1.91%+21.68%+76.50% 459B
+0.49%-5.19%+33.28%+35.53% 343B
+0.27%+3.26%+29.76%+47.50% 307B
+0.12%-2.11%+0.60%+12.03% 251B
-0.61%-0.89%+52.10%+71.80% 237B
+2.64%-1.08%-15.85%-53.97% 202B
-0.49%+0.91%+32.59%+98.83% 186B
Average +0.38%-2.49%+31.24%+51.34% 368.75B
Weighted average by Cap. +0.46%-3.29%+38.81%+67.73%

Financials

2026 *2027 *
Net sales 4.54B 5.27B 4.27B 3.89B 7.32B 500B 7.36B 50.52B 19.67B 254B 19.78B 19.35B 843B 4.64B 5.38B 4.36B 3.97B 7.47B 510B 7.51B 51.56B 20.07B 260B 20.18B 19.75B 861B
Net income 1.01B 1.17B 951M 866M 1.63B 111B 1.64B 11.24B 4.37B 56.57B 4.4B 4.3B 188B 985M 1.14B 927M 844M 1.59B 108B 1.6B 10.96B 4.27B 55.15B 4.29B 4.2B 183B
Net Debt -1.24B -1.44B -1.16B -1.06B -2B -136B -2.01B -13.77B -5.36B -69.29B -5.39B -5.27B -230B -2.3B -2.67B -2.16B -1.97B -3.71B -253B -3.73B -25.57B -9.95B -129B -10.01B -9.79B -427B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
02/09/26 167.70 0.00% 86,028
01/09/26 €167.70 +2.82% 96,017
31/08/26 €163.10 0.00% 108,721
28/08/26 €163.10 -3.61% 49,884
27/08/26 €169.20 +1.99% 112,273
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
167.70EUR
Average target price
167.07EUR
Spread / Average Target
-0.38%

Quarterly revenue - Rate of surprise